openPR Logo
Press release

Cyclin-Dependent Kinase Inhibitor Market Registering a Strong Growth by 2028

02-15-2019 07:51 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Future Market Insights

Cyclin-Dependent Kinase Inhibitor Market Registering a Strong

Cyclin-dependent kinase inhibitor function as tumor suppressor proteins by inhibiting the enzyme cyclin-dependent kinase. The enzyme cyclin-dependent kinase controls cell cycle progression, transcription, mRNA processing, and differentiation. Cyclin-dependent kinase inhibitor arrest cell cycle at the G1 phase leading to mitosis. Cyclin-dependent kinase inhibitors are employed in the treatment of cancers by preventing over proliferation of cancer cells. Cyclin-dependent kinase are very active in most cancers which is rational to the use of cyclin-dependent kinase inhibitor as anti-cancer agents.

Cyclin-Dependent Kinase Inhibitor Market: Drivers and Restraints

The growing demand generated due to increasing incidence of cancers owing to increasing exposure to risk factors such as carcinogens, sedentary lifestyles, substance abuse, pollution and others is driving a large market. According to the national cancer institute, prostate cancer accounted for 164,690 new cases in 2018 accounting for 9.5 % of all new cancer cases. The American Cancer Society’s estimates that about 63,340 new cases of kidney cancer are likely to occur in the United States in 2018.

The estimates for bladder cancer are about 81,190 new cases likely to occur in the United States in 2018. The growing geriatric population provides a strong impulse for the growth of the cyclin-dependent kinase inhibitor market. The number of people aged 60 years or older is expected to rise from 900 million to 2 billion between 2015 and 2050, representing a growth from 12% to 22% of the total global population, according to recent World Health Organization report. Thus a large cyclin-dependent kinase inhibitor market is well evident even to an untrained eye.

Request to Sample of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8708

A strong developmental pipeline is another driver of the market. There are more than 10 cyclin-dependent kinase inhibitors under clinical trials of which Trilaciclib shows great promise.

However the constraints such as high cost of treatment, and nascent stage of technology owing to poor understanding of cell cycle is hampering the cyclin-dependent kinase inhibitor market. The poor selectivity of cyclin-dependent kinase inhibitor is another hindrance to their adoption.

Cyclin-Dependent Kinase Inhibitor Market: Segmentation

To gain a bird’s eye view of the global cyclin-dependent kinase inhibitor market, the report is segmented on the spectrum, valve type, and region.

Based on the spectrum, the global cyclin-dependent kinase inhibitor market can be segmented as,

Broad CDK inhibitors
Specific CDK inhibitors
Multiple target inhibitors

Based on the formulation, the global Cyclin-Dependent Kinase Inhibitor market can be segmented as,

Inhaled
Tablet
Liquid
Injectable

Cyclin-Dependent Kinase Inhibitor Market: Regional Wise Outlook

The global cyclin-dependent kinase inhibitor market can be classified into the following region: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America, led by the U.S., is expected to drive the largest market share owing to the large incidence of cancer, attractive reimbursement large healthcare expenditure, and large per capita income.

The Asia Pacific cyclin-dependent kinase Inhibitor market excluding Japan is projected to expand and dominate the scene in the near future, owing to the growing healthcare.

China and India are anticipated to account for the major share of the Asia Pacific cyclin-dependent kinase inhibitor market growth. Germany, France and the U.K., are projected to be the largest drivers of the Europe cyclin-dependent kinase inhibitor market. The Middle East and Africa cyclin-dependent kinase inhibitor market is anticipated to be dominated by the gulf economies of Saudi Arabia, Kuwait, UAE and Qatar.

Request Report for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-8708

Cyclin-Dependent Kinase Inhibitor Market: Market Participants

Some of the major vendors operating in the global cyclin-dependent kinase inhibitor market are Eli Lilly and Company, Pfizer Inc., Novartis, Astex Pharmaceuticals, Merck KGaA, R&D Systems, Inc. and others.

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cyclin-Dependent Kinase Inhibitor Market Registering a Strong Growth by 2028 here

News-ID: 1590893 • Views: 173

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Inhibitor

Immune Checkpoint Inhibitor
Immune Checkpoint Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and indepth study on the current state of the global Immune Checkpoint Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Immune Checkpoint Inhibitors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an
Global C1 Esterase Inhibitor Market Research Report
This report studies the global C1 Esterase Inhibitor market status and forecast, categorizes the global C1 Esterase Inhibitor market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report CSL Behring Lev Pharmaceuticals Salix Pharmaceuticals Geographically, this report studies the top producers and consumers,
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways. Studies have shown the crucial roles of galectin in cancer as they contribute to tumour cell survival, tumour metastasis, angiogenesis and neoplastic transformation. Download the sample Report @ https://www.pharmaproff.com/request-sample/1209 Many studies have demonstrated role of galectins in the pathogenesis of various diseases including
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways. Studies have shown the crucial roles of galectin in cancer as they contribute to tumour cell survival, tumour metastasis, angiogenesis and neoplastic transformation. Download the sample Report @ https://www.pharmaproff.com/request-sample/1209 Many studies have demonstrated role of galectins in the pathogenesis of various diseases including
PAA Scale Inhibitor Market Research Report 2018
This report studies the global PAA Scale Inhibitor market status and forecast, categorizes the global PAA Scale Inhibitor market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-paa-scale-inhibitor-2018-674 The major manufacturers covered in this report BASF DOW Lubrizol Arkema Nippon Shokubai Toagosei Falizan Tasfyeh THWater Shandong Xintai Water Treatment Kairui Chemical Dongfang Chemical Huanuo Runyang Chemical Friend Water
B-Cell Inhibitor Market Research Report : 2017
Reports And Markets Publish a New Market Research Report On –"B-Cell Inhibitor Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-b-cell-inhibitor-market-research-report-2017-1541200 In this report, the global B-Cell Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions,